medicolegal aspects of vesicovaginal fistulae
TRANSCRIPT
![Page 1: Medicolegal aspects of vesicovaginal fistulae](https://reader036.vdocuments.us/reader036/viewer/2022081812/575024321a28ab877eadb2d4/html5/thumbnails/1.jpg)
Medicolegal aspects of vesicovaginal ®stulaeK. THOMAS and G. WILLIAMS
Department of Urology, Hammersmith Hospital, London
Introduction
Vesicovaginal ®stulae (VVF) are a common ®nding in
developing countries, because there is a high incidence of
prolonged obstructed labour [1±4]. In the Western world
VVF are less common and usually associated with
iatrogenic injury, especially obstetric and gynaecological
procedures [5±8]. VVF may also result from pelvic
malignancy and its treatment by radiotherapy [6,9].
The subsequent urinary incontinence caused by VVF has
a profound affect on the patient's quality of life and is a
common cause of medicolegal claims. This is frequently
compounded by an unnecessary delay in repair of up to 3
months from the time of injury [5,6].
For a small ®stula, the treatment is initially con-
servative, as a small percentage will heal spontaneously;
however, most will require surgery [10,11]. Operative
intervention is associated with an 80±90% primary cure
rate [1±7,12]. Surgery can be undertaken by either a
gynaecologist or urologist, provided they are a specialist
in the ®eld. The timing and type of repair used depend on
the experience of the surgeon and the aetiology of the
®stula [13].
The incidence of medicolegal claims is increasing,
especially in the ®eld of obstetrics and gynaecology.
Urological injury occurring during obstetric and gynae-
cological procedures accounts for 10% of all claims and
represents 19.6% of claims actually settled, with VVF
accounting for the second highest cause of claims within
gynaecology [14,15]. The avoidance, recognition and
treatment of these ®stulae is therefore a signi®cant issue
given the associated morbidity and medicolegal implica-
tions [16]. This review discusses the aetiology, presenta-
tion, management and prevention of obstetric, iatrogenic
and radiotherapy-induced VVF [17].
Surgical ®stulae
Aetiology
In developed countries iatrogenic injury during pelvic
surgery is the commonest cause of VVF. Abdominal
hysterectomy is the procedure most commonly impli-
cated, with the risk of ®stula formation quoted as 1 in
1300 hysterectomies [5±8]. The ®stula is usually found
in the vaginal vault [7,8,18]. The risk of causing VVF is
known to be increased by a variety of causes including:
anatomical distortion by ®broids or ovarian tumours,
adhesions between bladder and cervix after previous
surgery, sepsis, endometriosis or malignancy and pre-
vious radiotherapy [8,10]. Abnormal bladder function, in
particular a poor voiding pattern, has been implicated as
increasing the risk of ®stula formation through post-
operative urinary retention, which is often not
recognized early [10].
Presentation and diagnosis
Injuries may be recognized during surgery or present up
to 3 weeks later [5,6]. If iatrogenic injury to the bladder is
noticed at the time of surgery, then a senior clinician
should be informed and a urologist involved immediately
to repair the damage. If a urologist is not available, the
defect should be closed with an absorbable suture
(chromic catgut, polyglactin or polydioxanone) in two
or three layers, a catheter inserted, left on free
drainage and a urology review obtained after surgery.
Unfortunately, the injury is often not noticed intra-
operatively and the subsequent ®stula is not diagnosed
until later, despite persistent discharge through the
vagina after surgery. Fistulae are diagnosed a mean of
3 weeks after surgery, as the history is often subtle and
the opening of the ®stula small and dif®cult to ®nd [5,6].
A pelvic examination is mandatory and biochemical
con®rmation of the presence of urine advisable. IVU is
essential as concurrent ureteric damage is common [6]. If
it is dif®cult to establish the presence of a ®stula the three-
swab test can be used, but this does not identify multiple
®stulae. If the three-swab test is positive, methylene blue
should again be instilled into the bladder and a Sims
speculum used to identify the site(s) of the ®stulae. It is
important to adequately distend the bladder with
methylene blue and stop any leakage around the
catheter. If the swabs are soaked with clear ¯uid this
implies a ureteric injury which was not detected on IVU.
Oral pyridium is useful in these cases to colour the renal
urine (double-dye test) [19]. An examination under
anaesthesia can occasionally be necessary to detect
the track and plan the type of repair required more
accurately [20].
Recently there has been interest in documenting the
stability of the bladder before and after repair using
BJU International (2000), 86, 354±359
# 2000 BJU International354
![Page 2: Medicolegal aspects of vesicovaginal fistulae](https://reader036.vdocuments.us/reader036/viewer/2022081812/575024321a28ab877eadb2d4/html5/thumbnails/2.jpg)
urodynamics [21]. Hilton [21] suggested that the
incidence of detrusor instability and stress incontinence
in patients with vaginal vault ®stulae is lower than in
those with urethral or bladder neck ®stulae. Most of the
symptoms were found to resolve after repair, although an
element of detrusor instability requiring further treat-
ment persisted in some women. This contrasts with a
study based on the urodynamic assessment of women in
Nigeria after repair, 44% of whom were found to have
signi®cant stress incontinence despite a successful repair
[22]. This was a smaller study in patients who had
large ®stulae secondary to obstructed labour, requiring
more extensive surgery and bladder mobilization [22].
However, it is important to document any instability
before undertaking the repair, to prevent later allegations
suggesting that the repair has caused the problem [21].
Clinicians involved in surgery at risk of producing
these ®stulae must maintain a high index of suspicion
and refer any patient with a ®stula to a specialist unit for
her repair.
Management
If VVF are noticed < 24 h after surgery there is a case for
immediate repair; most ®stulae are diagnosed later and
thus the initial treatment is conservative, as some small
®stulae will heal spontaneously [8,10,11]. The bladder is
kept empty with an indwelling urethral catheter on free
drainage for 4±6 weeks. A suprapubic catheter should be
used for low ®stulae around the bladder neck or trigone,
to prevent pressure on the repair. Antibiotics are given to
prevent infection further jeopardising the health of the
tissues and complicating the ®stula. Steroid creams have
been claimed to improve healing but there is insuf®cient
evidence for routine use [23]. If after this time the ®stula
appears to have closed a cystogram should be performed
before the catheter is removed.
Most patients will require surgery, although the timing
and type of repair is controversial. The traditional
approach to the treatment of VVF is to delay surgery to
allow the tissues to re-vascularize [7]. This view has been
challenged by recent studies which show that if the
®stula had been caused by iatrogenic injury there is no
bene®t to delaying surgery, as the tissues are not unduly
indurated. Results for immediate repair are comparable
with those from previous reports favouring delayed repair
[5,24,25]. Obviously the advantage of an early repair is
an immediate improvement in quality of life. However, in
trying to achieve this the ef®cacy of the repair must not
be compromised, as the best chance of success is with the
®rst repair [1].
The approach depends on the site of the ®stula and the
preference of the surgeon. Gynaecologists often favour a
vaginal approach, whereas urologists tend to prefer an
abdominal approach. A vaginal approach, although
suitable for most ®stulae, is not recommended for high
®stulae, those with extensive surrounding induration
and those with involvement of the ureteric ori®ces [6,26].
The repair is also in¯uenced by previous surgery and any
associated injury requiring simultaneous repair. For
example, if a coexisting ureteric injury is present, an
abdominal approach would be more appropriate [27].
The most important factor is that the repair is performed
by a specialist in a specialist centre with appropriately
trained staff.
Speci®c operative measures are wide mobilization of
the scar and bladder using sharp dissection, and
emptying the bladder and opening the peritoneum
superiorly by sharp dissection (blunt dissection or
stretching of the wound can lead to bladder damage,
particularly in the presence of adhesions) [10]. The
ureters are protected by the passage of ureteric stents.
The basic principles of ®stula repair apply. The ®stulous
tract is excised to healthy, well-vascularized tissue and
the repair should be tension-free and multilayered
using absorbable sutures [6,16]. Various techniques to
improve the viability of the tissue have been described,
interposing well-vascularized tissues between the blad-
der and vagina. Examples of these are the Martius ¯ap
using a ¯ap of labial ®brofatty tissue, and the omental
¯ap [16,28±33]. The role of prophylactic antibiotics is
unclear, with most surgeons using a single dose of a
broad-spectrum agent at the time of repair. Thrombo-
embolic precautions (subcutaneous heparin and
stockings) must be taken, as this is high-risk pelvic
surgery.
After surgery patients are left with a urethral and/or
suprapubic catheter in situ for 4±6 weeks to allow
adequate healing. Patients with a ®stula at the bladder
neck or trigone should not be left with a urethral catheter
because of the risk of pressure on the repair. Nursing care
during this period is extremely important. The catheter
must be secure and not allowed to kink; often this is
easiest to ensure by placing the patient on bed rest.
Obviously if bed rest is imposed, thrombo-embolic
precautions should be continued. Accurate ¯uid charts
are essential; input and output should be charted hourly
in the ®rst few days, with urine output maintained at
100 mL/h until the urine becomes clear. Staff must be
alert to any evidence of a urethral or vaginal leak
indicating that the catheter is being bypassed. If this
occurs the catheter should be gently ¯ushed with a small
volume of sterile saline. Only in rare cases and with
appropriate medical consultation is the catheter changed
[10]. Well-trained nurses and vigilant nursing care are so
crucial to the success of the repair that if there is under-
staf®ng or no trained staff available then this type of
surgery should not be attempted.
VESICOVAGINAL FISTULAE 355
# 2000 BJU International, 86, 354±359
![Page 3: Medicolegal aspects of vesicovaginal fistulae](https://reader036.vdocuments.us/reader036/viewer/2022081812/575024321a28ab877eadb2d4/html5/thumbnails/3.jpg)
At 10±14 days after surgery a cystogram is performed
to ensure that there is no leak before removing the
catheter. If there is a persistent leak the catheter is left on
free drainage for 6 weeks to encourage healing and the
cystogram repeated. After removing the catheter, the
bladder capacity will be reduced by prolonged drainage.
Patients are encouraged to void hourly to avoid over-
distension of the bladder and compromise of the repair.
They can aim to resume a normal voiding pattern by one
month. Tampons, douches and sexual intercourse are to
be avoided until the patients are followed up 3 months
later [10,11].
Speci®c complications after repair of a ®stula include
ureteric injury, especially if the ®stula is close to the
ureteric ori®ces. This can be minimized by placing
ureteric stents during surgery [5]. Patients may develop
stress incontinence, although the results of recent studies
using urodynamics suggest this may have been present
before the repair was undertaken [21]. Vaginal stenosis
resulting in dyspareunia is a recognized but uncommon
complication [22]. To avoid any medicolegal problems
the patients should be informed of these speci®c
complications when consent is obtained for the repair.
It must also be made clear to the patient before surgery
that even in a specialist centre these repairs can have a
10% failure rate. In the event of a failed repair further
surgery is possible but the chance of success is diminished
to 60% [3]. This must be discussed with the patient and
the discussion documented in the notes.
Prevention
Given the association of VVF with hysterectomy, certain
simple measures can be adopted to reduce the risks of the
procedure. A hysterectomy identi®ed as high risk should
be performed by an experienced surgeon. If a high-risk
procedure is scheduled, involvement of a urologist
beforehand will ensure that the necessary expertise is
available quickly if required during surgery [34].
Speci®c operative techniques to minimize the risks of
®stula formation should be taken during any hyster-
ectomy regardless of whether the case is perceived as
high or low risk [26]. In particular, sharp dissection to
mobilize the bladder away from the cervix is preferable to
the use of swabs to develop the plane, as this also
increases the risk of damage to the bladder [8,22]. Before
clamping the ureterosacral ligaments, mobilization of the
inferior and lateral aspects of the bladder must be
completed and the ligaments taken close to the uterus to
avoid accidental damage to the bladder [20].
Areas identi®ed by the Medical Defence Union as
important in medicolegal claims were communication,
consent and case notes [14]. It is important for all doctors
to communicate with their patients both before and after
surgery, as patients who feel adequately informed are less
likely to claim in the event of an injury. Consent should
be obtained by a doctor suf®ciently familiar with the
procedure to accurately describe its complications. A
record of the explanation given and complications should
be recorded in the case notes, in addition to a signed
consent form [14]. Good documentation helps to avoid
litigation and provides good defence in the event of a
claim. Detailed operative notes should be made by the
surgeon who performed the operation and not by his
assistant. Any deviation from normality should be noted
and the use of words such as `routine, uncomplicated,
uneventful and straightforward' avoided [35]. Inade-
quate case notes were cited as the cause for settlement in
several claims [14,15,36].
Obstetric ®stulae
Aetiology
Obstructed labour is uncommon in the developed world
and obstetric-related ®stulae are usually secondary to an
instrumental delivery or injury to the bladder during a
lower segment Caesarean section [37]. In the developing
world, especially Africa, the main cause of VVF is
pressure necrosis secondary to obstructed labour [1±4].
During labour the bladder is displaced upwards whilst the
anterior vaginal wall, bladder base and urethra are
compressed between the fetal head and the pubis. If this
stage is prolonged the resultant ischaemia can cause
devitalization of tissues, leading to the formation of VVF
[1,2]. Women are usually poorly educated and live far
from medical facilities, with many having their ®rst child
at a young age, often before the pelvis is fully developed
[12]. This can lead to women being in labour for days
before seeking medical help. The risk is compounded in
women who have been circumcised, as this causes a
reduction in the size of the introitus, leading to obstructed
labour [38].
Presentation and diagnosis
The diagnosis of a ®stula is usually obvious as the patient
constantly leaks urine at about 10 days after injury. A
pelvic examination often reveals slough in the area
caused by extensive tissue loss [2,7]. In addition to the
investigations mentioned in the surgical section, IVU is
essential where the ureters may be damaged, e.g. after
Caesarean section.
Management
A ®stula caused during vaginal delivery can be treated
conservatively with a catheter initially, as a minority of
356 K. THOMAS and G. WILLIAMS
# 2000 BJU International, 86, 354±359
![Page 4: Medicolegal aspects of vesicovaginal fistulae](https://reader036.vdocuments.us/reader036/viewer/2022081812/575024321a28ab877eadb2d4/html5/thumbnails/4.jpg)
small ®stulae will heal this way [8,10,11]. Conservative
management is the same as described for surgical ®stulae,
with a catheter left on free drainage to allow the ®stula to
heal. Most ®stulae will require surgical repair. In these
®stulae this should be delayed for 3 months to allow the
tissues to re-vascularize. Obstetric ®stulae should be dealt
with in specialist centres, as even in experienced hands
the repairs have a 10% recurrence rate [1±7,12]. The
approach depends on the site of the ®stula and the
preference of the surgeon, as discussed for surgical
®stulae; the management during and after surgery is the
same, with nursing care being a critical factor in the
success of the repair.
Prevention
As well as taking precautions to prevent a ®stula it is
important to take measures to minimize the risk of
litigation if a ®stula is caused. The risk of ®stula formation
as a consequence of obstructed labour can be reduced by
appropriate training of staff, and following guidelines in
the management of the second stage of labour. Factors
such as congenital uterine abnormality, ®broids, primi-
gravida, scoliosis, small pelvis, large fetus and malposi-
tion are known to increase the risk of an obstructed
labour, and should be established during antenatal visits.
Appropriate precautions can then be taken, i.e. an
elective Caesarean section booked, or a trial of labour
closely monitored with staff available to proceed to
Caesarean section.
Forceps should only be used by a skilled operator who
understands the indications for using forceps [39]. If
junior staff are using forceps they must be trained when
to use them and how to apply them. Incorrect application
of forceps can cause lacerations to the anterior vaginal
wall extending into the bladder as a ®stula, as well as
causing fetal trauma. If forceps are considered during a
delivery it is important to document the indication and
preferably obtain written consent (although verbal
consent is adequate) [39]. After the procedure a
thorough description should be written in the notes
and any trauma, whether maternal or fetal, noted and
the patient informed.
If damage to the bladder is noticed during a Caesarean
section, senior advice should be sought and a urologist
contacted. If there is no urologist available the defect
should be closed with an absorbable suture in two or
three layers, a catheter inserted, left on free drainage and
a urology review obtained afterward. Obstetric trainees
should be aware of basic urological principles and be able
to perform a simple repair of a hole in the bladder if a
urologist is unavailable [40]. The injury must be
documented in the notes and a full explanation given
to the patient of the possible complications of a ®stula
[35].
From a medicolegal aspect the same principles of
thorough documentation, consent and communication
also apply to these ®stulae as to those of surgical
aetiology.
Radiotherapy
Aetiology
Whether used therapeutically or as an adjuvant, radio-
therapy increases the risk of VVF [9,10]. Before treatment
it decreases the vascularity of tissue, rendering it friable,
and impairs healing. Therapeutic radiotherapy causes
obliterative endoarteritis which progresses over years
and caused the late presentations of some ®stulae [10].
The presence of radiation damage also makes any
attempt to repair the ®stula less successful because of
poor healing.
Presentation and diagnosis
It is important to be aware that these ®stulae can present
many years after radiotherapy [5,10]. Therefore, if a
patient with a past history of radiotherapy presents with
incontinence, a ®stula must be included in the differential
diagnosis. The principles of investigation are as discussed
earlier.
Management
These ®stulae are often complex and must be managed in
a specialist centre. An abdominal approach is preferable
as they are often high ®stulae. The use of an omental ¯ap
is essential as the tissues are often poorly vascularized
[30±33]. Patients must be made aware of the high risk of
failure caused by poor tissue healing and given the option
of urinary diversion [6].
Prevention
The risk of producing these ®stulae can be reduced by
limiting the ®eld of exposure and the dose of radiation
given. During consent for radiotherapy the patient must
be warned of the risk of a late-onset ®stula and the
subsequent surgery this would involve, with the
possibility of a urinary diversion. This explanation
must be documented in the notes. It is then for the
patient and the radiotherapist to weigh the bene®ts of
treatment against the long-term risks. As always, good
documentation, consent and communication are impor-
tant in preventing and managing medicolegal claims.
VESICOVAGINAL FISTULAE 357
# 2000 BJU International, 86, 354±359
![Page 5: Medicolegal aspects of vesicovaginal fistulae](https://reader036.vdocuments.us/reader036/viewer/2022081812/575024321a28ab877eadb2d4/html5/thumbnails/5.jpg)
Discussion
The number of medicolegal claims continues to increase,
particularly within the ®eld of obstetrics and gynaecol-
ogy. This speciality accounts for 23.7% of the total claims
settled in hospital practice [14]. Individual payments are
increasing, with a total annual cost to the NHS estimated
at >£50 million. This has obvious implications for
budgets to clinical areas [41]. Doctors have a responsi-
bility to minimize the numbers of such claims and when
an injury occurs, to manage the patient's complaint in an
appropriate manner.
Injury to the genitourinary tract was found to be the
second major malpractice claim in gynaecology in a
study of 500 claims in Atlanta, with VVF ranking as the
second most common injury [15]. A worrying feature of
these claims was the failure by the surgeon to recognize
the signs and symptoms arising as a consequence of the
injury, with subsequent delays in treatment. Such errors
in management cause claims to be considered legally
indefensible and are therefore settled out of court. A
similar study in Britain by Lynch et al. [36] examined
500 medicolegal claims in obstetrics and gynaecology,
and found that 6% of claims in gynaecology were for
urinary tract injuries. The main causes for claims were
inexperienced surgeons and clumsy instrumentation. An
important point from both papers is the importance
of accurate documentation. Claims where notes are
missing or insuf®cient are extremely dif®cult to defend
[14,15,36]. In this review, we have attempted to address
these issues and give guidance about the medicolegal
aspects of VVF; by addressing these issues, doctors may
avoid many future claims.
References1 Elkins TE. Surgery for the obstetric vesico-vaginal ®stula.
Am J Obstet Gynecol 1994; 170: 1108±18
2 Kelly J. Vesico-vaginal and recto-vaginal ®stulae. J Royal Soc
Med 1992; 85: 257±8
3 Hilton P, Ward A. Epidemiological and surgical aspects of
urogenital ®stulae: a review of 25 years' experience in
Nigeria. Int Urogynaecol J 1995; 6: 243
4 Danso KA, Martey JO, Wall LL, Elkins TE. The epidemiology
of genito-urinary ®stulae in Kumasi, Ghana. Int Urogynaecol
J 1996; 7: 117±20
5 Blandy JP, Badenoch DF, Fowler CG, Jenkins BJ, Thomas
NWM. Early repair of iatrogenic injury to the ureter or
bladder after gynaecological surgery. J Urol 1991; 146:
761±5
6 O'Connor V. Review of experience with vesico-vaginal
®stula repair. J Urol 1980; 123: 367±9
7 Tancer ML. The post-total hysterectomy (vault) vesicova-
ginal ®stula. J Urol 1980; 123: 839±40
8 Tancer ML. Observations on prevention and management of
vesico-vaginal ®stulae after total hysterectomy. Surg
Gynaecol Obstet 1992; 175: 501±6
9 Leach GE, Trockman BA. Vesico-vaginal ®stulae. Surgery of
vesico-vaginal and urethro-vaginal ®stulae and urethial
diverticulum. In Walsh PC, Retik AB, Vaughan ED, Wein
AJ, eds. Campbell's Urology. 7th edn. Philadelphia: WB
Saunders, 1998
10 Shaw RW, Soutter WP, Stanton SL, eds. Fistulae. In
Gynaecology. 2nd edn. Edinburgh: Harcourt Publishers,
1997
11 Davits RJAM, Miranda SI. Conservative treatment of vesico-
vaginal ®stulas by bladder drainage alone. Br J Urol 1991;
68: 155±6
12 Kelly J. Ethopia. An epidemiological study of vesico-vaginal
®stulae in Addis Ababa. World Health Stat Q 1995; 48: 15±7
13 Blaivas JG, Heritz DM, Romanzi LJ. Early vs late repair of
vesico-vaginal ®stulas: vaginal and abdominal approaches.
J Urol 1995; 153: 1110±3
14 Medical Defence Union. Risk management in obstetrics and
gynaecology. J Med Def Union 1991; 2: 36±8
15 Ward CJ. Analysis of 500 obstetric, gynecologic malpractice
claims. Causes and prevention. Am J Obstet Gynecol 1991;
165: 298±305
16 Gerber GS, Schoenberg HW. Female urinary tract ®stulas.
J Urol 1993; 142: 229±36
17 Kursh ED, Morse RM, Resnick MI, Persky L. Prevention of
the development of a vesico-vaginal ®stula. Surg Gynecol
Obstet 1998; 166: 409±12
18 Lawson JB. Vesical ®stulae into the vaginal vault. Br J Urol
1972; 44: 623±31
19 Raghavaiah NV. Double dye test to diagnose various types
of vaginal ®stulas. J Urol 1974; 112: 811±2
20 Chassar Moir J. Vesico-vaginal ®stulae as seen in Britain.
J Obstet Gynaecol Br Com 1973; 80: 598±602
21 Hilton P. Urodynamic ®ndings in patients with urogenital
®stulae. Br J Urol 1998; 81: 539±42
22 Schleicher DJ, Ojengbede OHA, Elkins TE. Urological
evaluation after closure of vesico-vaginal ®stulas. Int
Urogynaecol J 1993; 4: 262±5
23 Collins CG, Pent D, Jones FB. Results of early repair of vesico-
vaginal ®stula with preliminary cortisone treatment. Am
J Obstet Gynecol 1960; 80: 1005
24 Persky L, Herman G, Guerrier K. Non delay in vesico-
vaginal ®stula repair. Urology 1979; 13: 273±5
25 Badenoch DF, Tipaft RC, Thaka DR, Fowler CG, Blandy JP.
Early repair of accidental injury to the ureter or bladder
following gynaecological surgery. Br J Urol 1987; 59: 516±
8
26 Rock JA, Thompson JD, eds. Hysterectomy. Te Linde's
Operative Gynecology. 8th edn. Philadelphia: Lippincott
Williams and Wilkins, 1997: 800±13
27 Wein AJ, Malloy TR, Carpiniello VL, Greenberg SH, Murphy
JJ. Repair of vesico-vaginal ®stula by a supra-pubic
transvesical approach. Surg Gynecol Obstet 1980; 150:
57±60
28 Wang Y. The use of rotated vascularized pedicle ¯aps for
complex transvaginal procedures. J Urol 1993; 149: 590±2
29 Margolis T, Elkins TE, Seffah J, Oparo-Addos HS, Fort D. Full
358 K. THOMAS and G. WILLIAMS
# 2000 BJU International, 86, 354±359
![Page 6: Medicolegal aspects of vesicovaginal fistulae](https://reader036.vdocuments.us/reader036/viewer/2022081812/575024321a28ab877eadb2d4/html5/thumbnails/6.jpg)
thickness Martius grafts to preserve vaginal depth. Obstet
Gynecol 1994; 84: 148±52
30 Turner-Warwick R. The use of the omental pedicle graft in
urinary tract reconstruction. J Urol 1976; 116: 341±7
31 Turner-Warwick R, Wynne EJC, Handley-Ashken M. The
use of the omental pedicle graft in repair and reconstruction
of the urinary tract. Br J Surg 1967; 54: 849±53
32 Wein AJ, Malloy TR, Greenberg SHC, Arpiniello VL, Murphy
JJ. Omental transposition as an aid in genito-urinary
reconstructive procedures. J Trauma 1980; 20: 473±7
33 Sharma SK, Bapna BC, Gupta CL et al. Pedicled omental
graft in repair of large dif®cult vesico-vaginal ®stulae. Int
J Gynaecol Obstet 1980; 17: 556±9
34 Neale G. Clinical analysis of 100 medico-legal cases. Br Med
J 1993; 307: 1483±7
35 Brudenell M. Medico-legal aspects of ureteric damage
during abdominal hysterectomy. Br J Ostet Gynaecol
1996; 103: 1180±3
36 Lynch CB, Coker A, Dua JA. A clinical analysis of 500
medico-legal claims evaluating the causes and assessing the
potential bene®t of alternative dispute resolution. Br J Obstet
Gynaecol 1996; 103: 1236±42
37 Kattan SA. Maternal urological injuries associated with
vaginal deliveries. Int Urol Nephrol 1997; 29: 155±61
38 Tahzib F. Epidemiological determinants of vesico-vaginal
®stulae. Br J Obstet Gynaecol 1983; 90: 387±91
39 Hankins GD, Clark SL, Gilstrap L III, Cunningham FG, eds.
Forceps delivery. Operative Obstetrics. 2nd edn. Maidenhead,
UK: Appleton and Lange, 1995
40 Moriel EZ, Meirow D, Zilberman M, Farkas A. Experience
with the immediate treatment of iatrogenic bladder injuries.
Arch Gynaecol Obstet 1993; 253: 127±30
41 Fenn P, Hermans D, Digwall R. Estimating the cost of
compensating victims of medical negligence. Br Med J 1994;
309: 389±91
AuthorsK. Thomas, FRCS, Research Fellow.
G. Williams, MS, FRCS, Consultant Urologist.
Correspondence: Miss K. Thomas, Research Fellow, Royal
College of Surgeons of England, 35±43 Lincoln's Inn Fields,
London WC2A 3PN.
VESICOVAGINAL FISTULAE 359
# 2000 BJU International, 86, 354±359